Cargando…

Validation of a digital identification tool for individuals at risk for hereditary cancer syndromes

BACKGROUND: The number of individuals meeting criteria for genetic counseling and testing for hereditary cancer syndromes (HCS) is far less than the number that actually receive it. To facilitate identification of patients at risk for HCS, Counsyl developed a digital identification tool (digital ID...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bucheit, Leslie, Johansen Taber, Katherine, Ready, Kaylene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330430/ https://www.ncbi.nlm.nih.gov/pubmed/30651894 http://dx.doi.org/10.1186/s13053-018-0099-8

Ejemplares similares

Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations
por: Vysotskaia, Valentina, et al.
Publicado: (2019)

Strategies for Improving Access to Hereditary Cancer Testing: Recommendations from Stakeholders
por: Ready, Kaylene, et al.
Publicado: (2019)

Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessment
por: Vysotskaia, Valentina S., et al.
Publicado: (2017)

Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing
por: Kang, Hyunseok P., et al.
Publicado: (2016)

Genomic-based tools for the risk assessment, management, and prevention of type 2 diabetes
por: Johansen Taber, Katherine A, et al.
Publicado: (2015)

Inherited Cancer in the Age of Next-Generation Sequencing
por: Price, Kristin S., et al.
Publicado: (2018)

Self-reported cancer family history is a useful tool for identification of individuals at risk of hereditary cancer predisposition syndrome at primary care centers in middle-income settings: a longitudinal study
por: Flória-Santos, Milena, et al.
Publicado: (2016)

Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool
por: Garutti, Mattia, et al.
Publicado: (2023)

Identification of high risk and early stage eating disorders: first validation of a digital screening tool
por: Bryant, Emma, et al.
Publicado: (2021)

Hereditary cancer syndromes
por: Imyanitov, Evgeny N, et al.
Publicado: (2023)

Clinical Impact of Polygenic Risk Score for Breast Cancer Risk Prediction in 382 Individuals with Hereditary Breast and Ovarian Cancer Syndrome
por: Stiller, Sarah, et al.
Publicado: (2023)

Hereditary cancer risk assessment: essential tools for a better approach
por: Gomy, Israel, et al.
Publicado: (2013)

Fragile X syndrome carrier screening accompanied by genetic consultation has clinical utility in populations beyond those recommended by guidelines
por: Johansen Taber, Katherine, et al.
Publicado: (2019)

Identification of Germline Variants in Patients with Hereditary Cancer Syndromes in Northeast Mexico
por: Pérez-Ibave, Diana Cristina, et al.
Publicado: (2023)

Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care
por: Ashton-Prolla, Patricia, et al.
Publicado: (2009)

Validation study of “Santé-Cerveau”, a digital tool for early cognitive changes identification
por: Lesoil, Constance, et al.
Publicado: (2023)

Awareness and uptake of genetic testing among individuals at-risk for hereditary colon cancer
por: Lowery, Jan T, et al.
Publicado: (2011)

A Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer Syndrome
por: Kardashian, Ani, et al.
Publicado: (2012)

Validation of an online questionnaire for identifying people at risk of familial and hereditary colorectal cancer
por: Kallenberg, F. G. J., et al.
Publicado: (2015)

Tumor Detection Rates in Screening of Individuals with SDHx-related Hereditary Paraganglioma-Pheochromocytoma Syndrome
por: Greenberg, Samantha E., et al.
Publicado: (2020)

Results of a pilot study to improve identification and referral for people at high risk for hereditary colorectal cancer syndromes
por: Leininger, Anna, et al.
Publicado: (2011)

Identification of individuals at high-risk for pancreatic cancer using a digital patient-input tool combining family cancer history screening and new-onset diabetes
por: Klatte, Derk C.F., et al.
Publicado: (2023)

Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties
por: Johansen Taber, Katherine A, et al.
Publicado: (2014)

Gastric Cancer: A Practical Review on Management of Individuals with Hereditary or Familial Risk for Gastric Cancer
por: Linhares, Marisa, et al.
Publicado: (2022)

Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer
por: Ponz de Leon, M, et al.
Publicado: (2004)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
por: Ewald, Ingrid Petroni, et al.
Publicado: (2016)

Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
por: Ewald, Ingrid P, et al.
Publicado: (2011)

Identification, Evaluation, and Treatment of Patients with Hereditary Cancer Risk within the United States
por: Cragun, Deborah, et al.
Publicado: (2013)

Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer
por: Campacci, Natalia, et al.
Publicado: (2017)

Hereditary colorectal cancer and Lynch syndrome
por: Rossi, Benedito M
Publicado: (2013)

Hereditary cancer syndromes: opportunities and challenges
por: Ashton-Prolla, Patricia
Publicado: (2013)

Rare Hereditary Gynecological Cancer Syndromes
por: Watanabe, Takafumi, et al.
Publicado: (2022)

Design and validation of an oligonucleotide microarray for the detection of genomic rearrangements associated with common hereditary cancer syndromes
por: Mancini-DiNardo, Debora, et al.
Publicado: (2014)

Genomic Screening Identifies Individuals at High Risk for Hereditary Transthyretin Amyloidosis
por: Soper, Emily R., et al.
Publicado: (2021)

OTHR-13. IDENTIFYING INDIVIDUALS WITH PRIMARY CENTRAL NERVOUS SYSTEM TUMORS AT RISK FOR HEREDITARY CANCER SYNDROMES USING A STATEWIDE CANCER REGISTRY
por: Whipple, Nicholas, et al.
Publicado: (2023)

Cancer-related worry and risk perception in Brazilian individuals seeking genetic counseling for hereditary breast cancer
por: Palmero, Edenir Inêz, et al.
Publicado: (2020)

RARE-24. IDENTIFYING INDIVIDUALS WITH PRIMARY CENTRAL NERVOUS SYSTEM TUMORS AT RISK FOR HEREDITARY CANCER SYNDROMES USING THE UTAH POPULATION DATABASE
por: Whipple, Nicholas, et al.
Publicado: (2021)

Adherence of Internet-Based Cancer Risk Assessment Tools to Best Practices in Risk Communication: Content Analysis
por: Waters, Erika A, et al.
Publicado: (2021)

Assessment of medical knowledge toward genetic testing for individuals with hereditary breast and ovarian cancer syndrome in Brazil
por: Lasta, João Lucas, et al.
Publicado: (2023)

Validation of a suspicion index to identify patients at risk for hereditary angioedema
por: Shams, Marissa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t3i7vh8lflmq6rfmanv0i1s4c9